artenimol has been researched along with Ureteral Obstruction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| An, XF; Chen, C; Chen, MM; Jiang, H; Liu, HL; Si, ZL; Su, K; Tan, NH; Vaziri, ND; Wang, LX; Wu, WH; Zhang, ZH; Zhou, W | 1 |
| Chen, X; Chen, Z; Dai, G; Du, Y; He, Y; Liu, P; Liu, Y; Mo, M; Xia, W; Zhang, B; Zhou, Y | 1 |
2 other study(ies) available for artenimol and Ureteral Obstruction
| Article | Year |
|---|---|
Dihydroartemisinin suppresses renal fibrosis in mice by inhibiting DNA-methyltransferase 1 and increasing Klotho.
Topics: Adenine; Animals; Artemisinins; Azacitidine; beta Catenin; Biotin; DNA; DNA Modification Methylases; Fibrosis; Glucuronidase; HEK293 Cells; Humans; Kidney; Klotho Proteins; Mice; Proteasome Endopeptidase Complex; Renal Insufficiency, Chronic; Transforming Growth Factor beta; Transforming Growth Factor beta1; Ubiquitins; Ureteral Obstruction | 2022 |
Dihydroartemisinin attenuates renal fibrosis through regulation of fibroblast proliferation and differentiation.
Topics: Animals; Artemisinins; Cell Differentiation; Cell Proliferation; Disease Models, Animal; Fibroblasts; Fibrosis; Kidney; Male; Mice, Inbred C57BL; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Ureteral Obstruction | 2019 |